EMD-43831

Single-particle
3.2 Å
EMD-43831 Deposition: 27/02/2024
Map released: 18/09/2024
Last modified: 02/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-43831

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9ato summary report (pdf.gz) Map-9ato FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

XBB.1.5 spike/Nanosota-3C complex

EMD-43831

Single-particle
3.2 Å
EMD-43831 Deposition: 27/02/2024
Map released: 18/09/2024
Last modified: 02/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Sample: XBB.1.5 spike/Nanosota-3C complex
Fitted models: 9ato

Deposition Authors: Ye G, Bu F, Liu B , Li F
Structure-guided in vitro evolution of nanobodies targeting new viral variants.
Ye G, Bu F, Pan R, Mendoza A, Yang G, Spiller B, Wadzinski BE, Du L, Perlman S, Liu B , Li F
(2024) PLoS Pathog , 20 , e1012600 - e1012600
PUBMED: 39325826
DOI: doi:10.1371/journal.ppat.1012600
ISSN: 1553-7374